Search General Info
Search Education
Search Partnering Companies

Mark Scheideler, PhD

Silver Spring, Maryland, United States
Dr. Scheideler works closely with the Charcot-Marie-Tooth Association to provide guidance to its research strategy and alliances. He is Chair of its Therapy Experts Advisory Board and directs the alliance testing network that is the subject of the presentation.

HumanFirst Therapeutics LLC (HFT) was founded in 2011 with the goal of accelerating new therapies towards clinical development, by providing the expertise needed to form, fund and operationally manage life science projects. HFT provides Managing Partner expertise to public-private partnerships aimed at drug development, to include: research direction; path-to-clinic planning; medicinal chemistry; project and consortium management; agreement support and patenting; and public funding. Clients have included Universities and Disease Foundations seeking to progress therapeutic opportunities, and Companies pursuing drug development via public sector collaboration.
Speaking In
[Available On-Demand]
The CMTA STAR (Strategy to Accelerate Research) Consortium was launched as a means to facilitate…